Long-term outcomes of Roux-en-Y gastric diversion after failed surgical fundoplication in a large cohort and a systematic review.


Journal

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
ISSN: 1878-7533
Titre abrégé: Surg Obes Relat Dis
Pays: United States
ID NLM: 101233161

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 29 05 2020
revised: 03 08 2020
accepted: 09 08 2020
pubmed: 10 10 2020
medline: 25 5 2021
entrez: 9 10 2020
Statut: ppublish

Résumé

Roux-en-Y gastric diversion (RNYG) is an alternative approach for patients with persistent or recurrent gastroesophageal reflux disease (GERD) after surgical fundoplication, especially in patients with esophageal dysmotility or morbid obesity, because redo fundoplication could offer unfavorable outcomes. To evaluate long-term outcomes of RNYG for failed fundoplication and its impact on esophageal function. A retrospective cohort study and a systematic review. Patients who underwent RNYG after failed fundoplication between 1995 and 2019 were identified. Surgical-related complications, GERD, dysphagia, and endoscopic and esophageal manometric findings were reviewed. A literature search for relevant studies was performed from several databases from database inception to September 2019. A total of 101 patients (mean age, 52.1 yr; 86.1% female; mean body mass index, 35.8 kg/m RNYG is an effective alternative surgery in a subset of patients with intractable symptoms who failed fundoplication. However, patients should be informed of the risks of postoperative GERD symptoms and dysphagia. Referral for a careful evaluation by a multidisciplinary foregut team is warranted.

Sections du résumé

BACKGROUND BACKGROUND
Roux-en-Y gastric diversion (RNYG) is an alternative approach for patients with persistent or recurrent gastroesophageal reflux disease (GERD) after surgical fundoplication, especially in patients with esophageal dysmotility or morbid obesity, because redo fundoplication could offer unfavorable outcomes.
OBJECTIVE OBJECTIVE
To evaluate long-term outcomes of RNYG for failed fundoplication and its impact on esophageal function.
SETTING METHODS
A retrospective cohort study and a systematic review.
METHODS METHODS
Patients who underwent RNYG after failed fundoplication between 1995 and 2019 were identified. Surgical-related complications, GERD, dysphagia, and endoscopic and esophageal manometric findings were reviewed. A literature search for relevant studies was performed from several databases from database inception to September 2019.
RESULTS RESULTS
A total of 101 patients (mean age, 52.1 yr; 86.1% female; mean body mass index, 35.8 kg/m
CONCLUSION CONCLUSIONS
RNYG is an effective alternative surgery in a subset of patients with intractable symptoms who failed fundoplication. However, patients should be informed of the risks of postoperative GERD symptoms and dysphagia. Referral for a careful evaluation by a multidisciplinary foregut team is warranted.

Identifiants

pubmed: 33032918
pii: S1550-7289(20)30480-9
doi: 10.1016/j.soard.2020.08.015
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

161-169

Informations de copyright

Copyright © 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Veeravich Jaruvongvanich (V)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States.

Reem H Matar (RH)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States.

Blake R Movitz (BR)

Division of Surgery, Mayo Clinic, Rochester, Minnesota, United States.

Karthik Ravi (K)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States.

Fnu Chesta (F)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States.

Daniel B Maselli (DB)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States.

Travis J McKenzie (TJ)

Division of Surgery, Mayo Clinic, Rochester, Minnesota, United States.

Todd A Kellogg (TA)

Division of Surgery, Mayo Clinic, Rochester, Minnesota, United States.

Michael L Kendrick (ML)

Division of Surgery, Mayo Clinic, Rochester, Minnesota, United States.

Barham K Abu Dayyeh (BK)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States. Electronic address: AbuDayyeh.Barham@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH